Search NLS News

Olink Holding has announced that Finnish FinnGen will use Olink technology to provide detailed proteomics data to improve understanding of human health. FinnGen is a large-scale academic/industrial research collaboration in Finland with the scope to collect and analyze genomic and health data from 500,000 Finnish biobank participants. It is one of the very first personalized […]

There is a massive need for medicines and medical care in war-torn Ukraine, but getting aid supplies through is virtually impossible. At the same time, the Swedish healthcare service faces medical challenges as Ukrainian refugee patients arrive in Sweden. Bengt Mattson, special adviser at the trade association for the research-based pharmaceutical industry in Sweden (Lif), […]

TILT Biotherapeutics has completed the first close of its financing round raising 10.7 million USD. The round was led by Lifeline Ventures and was joined by Tesi (Finnish Industry Investment Ltd). “We support resilient founders. We saw early on the enormous potential in TILT’s innovative approach to boost the patient’s T cell immune response to […]

BioLamina has announced plans to open an office in the US to further fuel company growth and market expansion. The new office will be in Boston, MA. This strategic move will help BioLamina to better support existing and new customers in the US and brings the company closer geographically to world-renowned science hubs, it states. […]

Lytix Biopharma has announced data from its ATLAS-IT-04 trial in patients with metastatic soft tissue sarcoma (STS). The data from this Phase II proof of concept study shows that LTX-315 in combination with Adoptive Cell Therapy (ACT) was able to stabilize the disease in 3 out of 4 fully treated patients in this hard-to-treat patient […]

The Public Health Agency of Canada (PHAC) will be purchasing IMVAMUNE smallpox vaccine at a value of approximately USD 56 million. The non-replicating smallpox vaccine is also approved for use against monkeypox in Canada as the only territory other than the USA. Deliveries of vaccines under this five-year contract are expected to occur from 2023. […]

As Chief Medical Officer (CMO) at Faron Pharmaceuticals Marie-Louise Fjällskog can combine her passion for science and helping people with her fascination for finding solutions to detective stories. The first thing that attracted Marie-Louise Fjällskog about Faron Pharmaceuticals was the science. She says, “They have had many interesting publications in highly rated journals and a […]

Scientists at Karolinska Institutet and Stockholm University have visualized in detail the machinery that the mitochondria use to form their proteins. The mitochondria convert energy locked in our food into a functional “energy currency” for the cells. They also have their own protein synthesis factories called ribosomes, which have a different appearance to those found […]

The latest Nature Biotechnology World Review shows the growing strength of the Nordics as a leading life sciences hub. Judged on five pillars, Sweden ranks second to winner Switzerland, Denmark is fifth, Finland ninth – and Norway lies just outside at 13th.  Meanwhile, Iceland ranked highest in the sub-category of nations with no headquartered biotech […]

BioInvent International has announced the appointment of Sylvie Ryckebusch as Chief Business Officer (CBO). “Sylvie Ryckebusch has already made an important contribution to the development of BioInvent’s business, including the licensing deal with CASI Pharmaceuticals in 2020, the restructuring of a clinical development agreement with Cancer Research UK in 2021, and a supply and clinical […]